Abstract
OBJECTIVES--The aim of this investigation was to study the glomerular and tubular effects of low doses (15 mg) of methotrexate in patients with rheumatoid arthritis with and without combined treatment with aspirin (2 g single dose). METHODS--Renal function was measured by the plasma clearance of EDTA labelled with chromium-51 (51Cr-EDTA) and mercaptoacetyltriglycine labelled with technetium-99m (99mTc-MAG-3). RESULTS--Clearance of 51Cr-EDTA was reduced from 98 (6) to 87 (5) ml/min (mean (SEM)) for patients receiving methotrexate only and further reduced to 76 (5) ml/min for patients receiving methotrexate and aspirin. This effect was reversible as 51Cr-EDTA increased to 85 (6) ml/min during continued treatment with methotrexate alone. Clearance of 99mTc-MAG-3 also decreased from 366 (18) to 315 (17) ml/min in patients receiving methotrexate alone and further to 295 (17) ml/min during treatment with aspirin and methotrexate. Continued treatment with methotrexate alone resulted in a further decrease in the 99mTc-MAG-3 clearance to 253 (17) ml/min. CONCLUSIONS--The study shows that treatment with low doses of methotrexate particularly when combined with aspirin affects glomerular and tubular function. These effects may be of clinical importance and renal function should therefore be monitored with more sensitive methods than serum creatinine as this may not reflect these changes.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bröchner-Mortensen J. A simple method for the determination of glomerular filtration rate. Scand J Clin Lab Invest. 1972 Nov;30(3):271–274. doi: 10.3109/00365517209084290. [DOI] [PubMed] [Google Scholar]
- Bröchner-Mortensen J., Rödbro P. Selection of routine method for determination of glomerular filtration rate in adult patients. Scand J Clin Lab Invest. 1976 Jan;36(1):35–43. doi: 10.1080/00365517609068016. [DOI] [PubMed] [Google Scholar]
- Ellison N. M., Servi R. J. Acute renal failure and death following sequential intermediate-dose methotrexate and 5-FU: a possible adverse effect due to concomitant indomethacin administration. Cancer Treat Rep. 1985 Mar;69(3):342–343. [PubMed] [Google Scholar]
- Grigor R. R., Spitz P. W., Furst D. E. Salicylate toxicity in elderly patients with rheumatoid arthritis. J Rheumatol. 1987 Feb;14(1):60–66. [PubMed] [Google Scholar]
- Maiche A. G., Lappalainen K., Teerenhovi L. Renal insufficiency in patients treated with high dose methotrexate. Acta Oncol. 1988;27(1):73–74. doi: 10.3109/02841868809090322. [DOI] [PubMed] [Google Scholar]
- Müller-Suur R., Magnusson G., Bois-Svensson I., Jansson B. Estimation of technetium 99m mercaptoacetyltriglycine plasma clearance by use of one single plasma sample. Eur J Nucl Med. 1991;18(1):28–31. doi: 10.1007/BF00177681. [DOI] [PubMed] [Google Scholar]
- Müller-Suur R., Müller-Suur C. Glomerular filtration and tubular secretion of MAG-3 in the rat kidney. J Nucl Med. 1989 Dec;30(12):1986–1991. [PubMed] [Google Scholar]
- Seideman P., Sollevi A., Fredholm B. B. Additive renal effects of indomethacin and dipyridamole in man. Br J Clin Pharmacol. 1987 Mar;23(3):323–330. doi: 10.1111/j.1365-2125.1987.tb03052.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stark A. N., Jackson G., Carey P. J., Arfeen S., Proctor S. J. Severe renal toxicity due to intermediate-dose methotrexate. Cancer Chemother Pharmacol. 1989;24(4):243–245. doi: 10.1007/BF00257626. [DOI] [PubMed] [Google Scholar]
- Stewart C. F., Fleming R. A., Germain B. F., Seleznick M. J., Evans W. E. Aspirin alters methotrexate disposition in rheumatoid arthritis patients. Arthritis Rheum. 1991 Dec;34(12):1514–1520. doi: 10.1002/art.1780341207. [DOI] [PubMed] [Google Scholar]